Abstract

ABSTRACTWe study the capability of hydrophilic polymers (HPs) to reverse the inhibitory effect of albumin and to restore the surface activity of lipid-protein lung surfactants preparations (LSPs): Curosurf and Survanta. HPs implied are dextran and Polyethylene glycol 10000 (PEG10000). LSPs surface activity is evaluated in Thin Films (monolayer and foam) at the air/water interface. Albumin displaces LSP from the interface and inhibits their ability to sustain low surface tension in monolayers and to form stable thin foam films (FFs). When HPs are added to monolayers they restore the surface activity of LSPs and recover their capability to maintain low dynamic surface tensions. Similarly the inclusion of HPs in foam films results in neutralization of the effect of albumin and in formation of stable, thin (with thickness <17 nm) films with homogeneous surfaces, as in the case of pure LSPs. Our findings permit to search for the answer of the intriguing problem why PEG recovers better the surface activity of Survanta, while Dextran—of Curosurf. Such results might be of major importance for the treatment of Adult Respiratory Distress Syndrome.

Full Text
Paper version not known

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.